Physician profile
Steven Jay Levine
NPI 1841225950
$221.85
in general payments reported to CMS, 2019-2025
9 companies · $21.00 in 2025
The $21.00 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $66.17 · 2020: $24.84 · 2021: $42.62 · 2022: $48.74 · 2024: $18.48 · 2025: $21.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $39.48.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $39.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $42.62 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $27.27 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $25.38 | 2022 | |
| Abiomed | $24.84 | 2020 | |
| Novo Nordisk INC | $23.36 | 2022 | |
| Janssen Pharmaceuticals, INC | $23.27 | 2019 | |
| Abbott Laboratories | $21.00 | 2025 | Perclose Prostyle |
| Amgen INC. | $18.48 | 2024 | Repatha |
| Bardy Diagnostics, INC. | $15.63 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Levine listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.